Volume 11, Number 7—July 2005
Dispatch
Bordetella petrii Clinical Isolate
Norman K. Fry*
, John Duncan*, Henry Malnick*, Marina Warner*, Andrew J. Smith†, Margaret S. Jackson†, and Ashraf Ayoub†
, John Duncan*, Henry Malnick*, Marina Warner*, Andrew J. Smith†, Margaret S. Jackson†, and Ashraf Ayoub†
Table
Results of antimicrobial drug–susceptibility testing for strain GDH030510
| Antimicrobial agent | MIC (μg/mL) |
|---|---|
| Penicillin | >32 |
| Ampicillin | >256 |
| Piperacillin/tazobactam | 2 |
| Ceftriaxone | >32 |
| Cefotaxime | >32 |
| Ceftazidime | 32 |
| Imipenem | >32 |
| Meropenem | >32 |
| Ertapenem | >32 |
| Amikacin | >256 |
| Gentamicin | 4 |
| Tobramycin | 16 |
| Ciprofloxacin | >32 |
| Erythromycin | 128 |
| Azithromycin | 4 |
| Clarithromycin | 64 |
| Clindamycin | >256 |
| Chloramphenicol | >256 |
| Cotrimoxazole | 8 |
| Rifampin | >32 |
| Tetracycline | >256 |
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.